Category : Search result: semaglutide India


India-Russia Summit: Key Outcomes & UPSC Insights

India & Russia sign 16 pacts, chart roadmap till 2030. Key takeaways on labour mobility, trade, defence & nuclear energy. Essential analysis for UPSC aspirants on bilateral ties, repo rate, labour codes & more.

India's Drug Patent Wars: Need for Special Courts?

A recent Delhi High Court order in the Novo Nordisk vs Dr Reddy's case highlights the complexities of Indian patent litigation. We examine the system's challenges and the push for specialized IP courts.

Putin's India Visit: Oil, Defence & US Pressure

As Putin visits India, the world watches how New Delhi will balance discounted Russian oil, defence needs, and US pressure. Will India secure its autonomy or face new sanctions?

IMF Forecasts 6.6% Growth for India in FY2025-26

IMF's latest assessment reveals India's strong economic outlook with 6.6% growth forecast. Discover how prudent policies and structural reforms drive sustained growth and reduce poverty.

Indian Companies Set for Semaglutide Device Windfall

Shaily Engineering and Gland Pharma positioned to benefit from India's semaglutide gold rush as patent expiry opens market for generic weight-loss drugs. Discover how these companies are preparing.

10 Indian Winter Getaways With European Vibes

Discover 10 breathtaking Indian destinations that offer European winter charm without international travel. Perfect winter escapes with snow, architecture & alpine vibes.

White House Deal Cuts Ozempic & Wegovy Prices in India

In a major breakthrough for weight management, the White House has secured a deal that significantly reduces prices of popular drugs Ozempic and Wegovy, making effective weight loss treatment more accessible across India.

India's ₹10,372 Cr AI Mission: PM Modi's Tech Revolution

Prime Minister Narendra Modi announces massive ₹10,372 crore investment in India's AI ecosystem, positioning the nation as global artificial intelligence leader with focus on computing infrastructure and startup innovation.

Obesity Drugs: Not Miracle Cures

Discover why revolutionary weight-loss drugs aren't magic bullets for India's obesity crisis. Learn about limitations, costs, and sustainable solutions.

Trump's $149 Weight-Loss Drug Deal with Ozempic Maker

Former US President Donald Trump is negotiating with Novo Nordisk to offer weight-loss drugs at just $149. Discover how this could revolutionize affordable healthcare and impact India's growing obesity crisis.

ChatGPT Free in India: Access AI Chatbot Now

OpenAI makes ChatGPT available for free to Indian users through Microsoft's Bing integration. Discover the benefits, limitations, and how to access this revolutionary AI tool.

India Outpaces China in Generative AI Adoption

New analysis reveals India's surprising lead over China in generative AI adoption. Discover how Indian professionals and businesses are leveraging tools like ChatGPT and DeepSeek to boost productivity and drive economic growth.

India Manufacturing PMI Hits 58.5 in October

India's manufacturing activity accelerated significantly in October 2024, driven by robust domestic demand and improved business conditions. The HSBC India Manufacturing PMI climbed to 58.5, marking one of the strongest growth rates in over three years.

Page 1 of 4